Improved survival of critically III trauma patients treatedwith recombinant human erythropoietin

Lena M. Napolitano, Timothy C. Fabian, Kathleen M. Kelly, Jeffrey A. Bailey, Ernest F. Block, Wayne Langholff, Christopher Enny, Howard L. Corwin

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Epoetin alfa demonstrated a survival advantage in both of the critically ill trauma patient cohorts of two prospective, randomized clinical trials, which was not affected by baseline factors including trauma-specific variables. A definitive study in trauma subjects is warranted.

Original languageEnglish
Pages (from-to)285-297
Number of pages13
JournalJournal of Trauma - Injury, Infection and Critical Care
Volume65
Issue number2
DOIs
StatePublished - Aug 2008

Keywords

  • Anemia
  • Epoetin alfa
  • Intensive care unit
  • Mortalty
  • Outcome
  • Trauma

Fingerprint

Dive into the research topics of 'Improved survival of critically III trauma patients treatedwith recombinant human erythropoietin'. Together they form a unique fingerprint.

Cite this